St. Jude Medical Inc (STJ.N)
30 Jun 2016
* Announces European launch of latest in PressureWire Guidewire technology to measure pressure differences across narrowed coronary arteries
May 10 Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Your Community Bankshares, Kohls and Nordic American Tanker, on Tuesday. HIGHLIGHTS * Aflac Inc : FBR cuts to market perform rating * Sprouts Farmers market Inc : Goldman Sachs cuts to sell from neutral * Hasbro Inc : Piper Jaffray cuts to neutral from overweight * St. Jude Medical Inc : SunTrust
* Sets quarterly dividend of $0.31per share Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
NEW YORK When Abbott Laboratories said on Thursday it would buy heart device company St. Jude Medical Inc for $25 billion, it set off a flurry of Wall Street speculation over whether Abbott Chief Executive Miles White is laying groundwork to split the company yet again.
NEW YORK, April 28 When Abbott Laboratories said on Thursday it would buy heart device company St. Jude Medical Inc for $25 billion, it set off a flurry of Wall Street speculation over whether Abbott Chief Executive Miles White is laying groundwork to split the company yet again.
(The following statement was released by the rating agency) CHICAGO, April 28 (Fitch) Fitch Ratings has placed St. Jude Medical, Inc. (STJ, St. Jude) on Rating Watch Negative. The rating action follows Abbott Laboratories' (ABT, Abbott) announcement of its intention to acquire St. Jude. Fitch will resolve the Rating Watch as more details regarding the transactions become available. However, given the currently available information and assuming Abbott acquires both Alere and St. Jude, Fitch
BRIEF-S&P- Abbott Laboratories ratings remain on creditwatch negative on planned acquisition of St. Jude
* Abbott Laboratories ratings remain on creditwatch negative on planned acquisition of St. Jude Medical Source text: (http://bit.ly/21hkyCp) (Bengaluru Newsroom +91 80 6749-1130; within U.S. +1 646 223 8780)
* Transaction expected to be accretive to abbott's adjusted earnings per share(1) in first full year after closing and increasing thereafter
April 28 Abbott Laboratories said it agreed to buy medical device maker St. Jude Medical Inc for $25 billion.
St. Jude Medical Inc reported better-than-expected quarterly results helped by strong heart failure device sales and said it was making progress in getting its pacemaker and defibrillator business back on track.
|Johnson & Johnson (JNJ.N)||$121.30||+1.97|
|Abbott Laboratories (ABT.N)||$39.31||+0.74|
|Edwards Lifesciences Corp (EW.N)||$99.73||+2.82|
|Boston Scientific Corporation (BSX.N)||$23.37||+0.34|
|Nevro Corp (NVRO.N)||$73.76||+2.07|
|Medtronic PLC (MDT.N)||$86.77||+1.32|
|LivaNova PLC (LIVN.L)||$49.50||0.00|
|Stryker Corporation (SYK.N)||$119.83||+1.02|
|Cardinal Health Inc (CAH.N)||$78.01||+0.72|
|Koninklijke Philips NV (PHG.AS)||€22.30||-0.09|
Earnings vs. Estimates
Analyst Research Reports
Provider : Thomson Reuters Stock Report
Provider : New Constructs, LLC
Provider : Wright Reports
Trading Report for (STJ). A detailed report, including free correlated market analysis, and updates.
Provider : Stock Traders Daily
Provider : ValuEngine, Inc.
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.